A set of phantoms was produced for validating the new spectral metrics described below. These phantoms used serial dilution of a mixture of indocyanine green (ICG) dye and Intralipid 20% with saline solution. ICG is a common fluorescent dye used in ophthalmic imaging, which was used here to provide a variable absorption profile across the measured wavelength band from 803 nm to 888 nm (
Fig. 1E). Intralipid is an emulsion of fat particles that was used here to backscatter and depolarize
23 the incident light. Intralipid does not have strong spectral characteristics and is not expected to interfere with the ICG spectral signal. A mixture of 5 mg/mL ICG and Intralipid 20% was initially prepared at a 1:4 ratio and diluted by saline solution in ratios of 1:4:1, 1:4:2, 1:4:3, 1:4:4, 1:4:5, and 1:4:95, yielding concentrations of 1290 µM, 1075 µM, 922 µM, 806 µM, 717 µM, 645 µM, and 64.5 µM for ICG and 16%, 13.3%, 11.4%, 10%, 8.9%, 8%, and 0.8% for Intralipid (
Fig. 2C). Each dilution was freshly mixed, collected in a glass capillary tube, and imaged in a fixed mount using a custom-built PS-OCT system.
24 The combination of Intralipid and ICG in a single phantom enables both depolarization and spectral characteristics to be measured simultaneously in a single scan. This ensures that the dilution of both components is identical and that other sources of variance such as phantom orientation are reduced. Simulations of expected spectral metrics were also performed based on known ICG absorption profiles in albumin and water at 1290 µM, 645 µM, and 64.5 µM concentrations.
25 These simulations used the Beer-Lambert law with the known absorption coefficients at 20 wavelengths corresponding to the full bandwidth of our OCT system to estimate the spectral intensities up to 200 µm in depth within these different solutions. Because OCT measures backscattered light, the roundtrip distance into and out of the medium is used in this simulation.